查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1801174

2025 年至 2033 年痤瘡藥物市場規模、佔有率、趨勢及預測（按痤瘡類型、藥物類別、藥物類型、給藥途徑和地區分類）

Acne Drugs Market Size, Share, Trends and Forecast by Acne Type, Drug Class, Drug Type, Route of Administration, and Region, 2025-2033
出版日期: | 出版商: IMARC | 英文 138 Pages | 商品交期: 2-3個工作天內

價格

2024年，全球痤瘡藥物市場規模達72億美元。展望未來， IMARC Group預計到2033年，該市場規模將達到112億美元，2025-2033年期間的複合年成長率（CAGR）為4.9%。市場成長的主要驅動力包括：成人和青少年痤瘡盛行率的上升、人們對護膚的認知和重視程度的提升、創新療法藥物研發的持續進步，以及社交媒體影響力的不斷增強。

全球痤瘡藥物市場趨勢：

痤瘡盛行率不斷上升

全球成年人和青少年中痤瘡盛行率的不斷上升是推動痤瘡藥物市場統計數據成長的主要原因。此外，青春期荷爾蒙變化的加劇、個人壓力水平的高漲以及不良飲食和不充分的皮膚護理等多種生活方式因素預計將推動市場成長。除此之外，各大製藥公司為創新、方便和可靠的痤瘡藥物所做的廣泛研發工作也對市場擴張產生了正面影響。例如，ClickPharmacy 發布的資料顯示，34% 的英國成年人在一生中的某個階段都曾患過痤瘡。同一消息來源提到，目前男性患有痤瘡的比例為 6.1%，而女性的比例為 2.5%。此外，《薩赫勒醫學雜誌》發表的文章提到，南奈及利亞尋常性痤瘡的盛行率為 37.3%，女性盛行率（37.6%）高於男性（36.7%）。有鑑於此，許多關鍵參與者正致力於推出合適的痤瘡治療方案，以惠及廣大痤瘡患者。例如，2023年6月，太陽製藥工業有限公司（Sun Pharmaceutical Industries Ltd.）的WINLEVI乳膏獲得了加拿大衛生部（該國衛生監管機構）的批准，用於治療痤瘡和痤瘡疤痕。

護膚意識和重視程度不斷提高

人們對護膚和個人形象的日益重視和關注，促進了痤瘡藥物市場的成長。此外，尤其是在發展中經濟體，個人在護膚產品和有助於打造潔淨無瑕肌膚的療法上的支出不斷成長，也催化了全球市場的發展。此外，社群媒體和名人代言的影響力日益增強，以及對改善膚質療法的需求不斷成長，也對市場成長產生了正面的影響。例如，高德美公司推出了一項名為「做我自己」的全新數位行銷活動，推廣Aklief（三氟甲磺酸）乳膏的局部痤瘡治療。該公司向患者普及了Aklief的知識，這是20多年來首個獲準用於治療尋常性痤瘡的新型類維生素A分子。此外，Stryke Club還推出了Knockout Adapalene凝膠，用於治療類維生素A痤瘡，可預防粉刺、黑頭、白頭和毛孔阻塞。此外，2023年9月，Marksans Pharma完成對印度Teva Pharmaceuticals的收購，以繼續為客戶和患者不間斷地供應Teva的重要藥品。

藥物研發的進步

藥物研發領域的不斷進步，為痤瘡治療創造了創新且更有效率的配方，這對市場成長產生了積極的影響。此外，監管機構在研究和引進最新改良型痤瘡藥物方面不斷增加的投資，也推動了市場擴張。此外，改進的藥物傳輸系統的日益普及、新型活性成分的發現以及針對痤瘡各個方面的聯合療法的廣泛採用，進一步促進了痤瘡藥物市場的收入成長。例如，高德美公司在馬薩諸塞州波士頓舉行的美國皮膚病學會 (AAD) 年會上宣佈在美國推出其 0.1%/3% 的「Twyneo」乳膏。 TWYNEO 乳膏是第一個也是唯一一個經證實可快速治療中度至重度臉部痤瘡的 0.1% 維他命A酸和 3% 過氧化苯甲醯 (BPO) 二合一組合產品。此外，2023年5月，博士倫醫療公司（Bausch Health Companies Inc.）宣布，美國食品藥物管理局（FDA）根據處方藥使用者付費法案（PDUFA）接受了試驗性IDP-126（克林黴素1.2%/阿達帕林0.15%/過氧化苯甲醯3.1%）凝膠的新藥申請（NDA）凝膠的新藥申請（NDA）。

全球痤瘡藥物市場細分

根據痤瘡類型分手：

  • 粉刺性
  • 發炎
  • 囊性
  • 手術後/傷口

在粉刺性痤瘡領域，非發炎性痤瘡的高發病率、非處方藥日益普及以及人們對潔淨無瑕肌膚的渴望，是市場成長的主要驅動力。此外，對強效抗發炎藥物日益成長的需求，以及為開發有效痤瘡治療方案而進行的持續研究，也催化了發炎性痤瘡市場的發展。此外，處方藥需求的不斷成長、先進療法的日益普及、術後護膚要求的不斷提高以及美容手術的興起，都在推動囊性痤瘡和術後/傷口痤瘡藥物市場的擴張。

按毒品類別分類：

  • 類視黃酸
  • 抗生素
  • 荷爾蒙藥物
  • 聯合用藥
  • 其他

類視黃醇佔據市場主導地位

人們對使用類維生素A治療痤瘡的認知不斷提高，這在很大程度上推動了該領域的市場成長。此外，由於類維生素A能夠調節皮膚細胞更新、預防粉刺（黑頭和白頭）形成以及減少炎症，醫護人員和個人對有效痤瘡治療產品的需求也十分廣泛，這也進一步促進了市場的成長。

依毒品類型分類：

  • 非處方藥
  • 處方藥

非處方藥 (OTC) 的便捷獲取以及個人護理方案日益成長的興趣，推動了痤瘡藥物市場在這一領域的成長。此外，消費者對常見皮膚問題的速效療法的需求日益成長，這些療法在超市、藥局和線上商店隨處可見，也對全球痤瘡藥物的需求產生了積極影響。例如，太陽製藥 (Sun Pharma) 與 TLC 電視網的皮膚科醫生 Sandra Lee 博士合作，透過名為「啊哈！痤瘡激素」的活動，重點關注激素在皮膚痤瘡根本病因中的作用。該活動邀請了不同年齡、性別和種族的人群，指導美國民眾遵循可能涉及 OTC 產品的有效皮膚護理方案。

依給藥途徑分類：

  • 外用
  • 口服
  • 注射劑

外用藥物在市場上佔有最大佔有率

局部治療的便利性對痤瘡藥物市場前景至關重要，因為這些產品易於直接塗抹於患處，使其成為許多尋求局部痤瘡治療人士的首選。此外，製藥業持續的研發工作，旨在推出副作用更少、療效更佳的創新配方，也催化了該領域的市場成長。例如，美國食品藥物管理局 (FDA) 批准了 Opzelura（蘆可替尼），這是一款用於治療 12 歲及以上無法使用其他療法或無法從其他療法中獲得足夠症狀緩解的輕度至中度異位性皮膚炎患者的乳膏。

按地區分類：

  • 北美洲
    • 美國
    • 加拿大
  • 亞太
    • 中國
    • 日本
    • 印度
    • 韓國
    • 澳洲
    • 印尼
    • 其他
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙
    • 俄羅斯
    • 其他
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他
  • 中東和非洲

北美佔據明顯優勢，佔據痤瘡藥物市場最大佔有率

該報告還對所有主要區域市場進行了全面分析，包括北美（美國和加拿大）；亞太地區（中國、日本、印度、韓國、澳洲、印尼等）；歐洲（德國、法國、英國、義大利、西班牙、俄羅斯等）；拉丁美洲（巴西、墨西哥等）；以及中東和非洲。報告顯示，北美佔據了最大的市場佔有率。

北美是痤瘡藥物市場最大的細分市場，這得益於其先進的醫療基礎設施和不斷成長的個人消費能力。此外，青少年和成年人痤瘡的高發病率、先進醫療技術的發展以及醫療專業人員和皮膚科醫生的便利就診，也催化了該地區市場的成長。此外，個人對保持外表和美麗的日益成長的追求也對市場成長產生了積極的影響。例如，在加拿大，博士倫醫療的子公司Ortho Dermatologics公佈了其IDP-126第二階段III期臨床試驗的積極資料。 IDP-126是一種由三種化合物組成的複合凝膠，在193名尋常性痤瘡患者中進行了測試。此臨床試驗表明，在第12週，兩種痤瘡患者的發炎和非發炎性病變均有所減少。 IDP-126結合了阿達帕林、視黃醇和抗菌過氧化苯甲醯。

競爭格局：

全球痤瘡藥物市場的競爭格局以眾多製藥和醫療保健公司為特色，這些公司致力於提供創新有效的痤瘡治療解決方案。應用戶要求，本文未提及具體參與者，但值得注意的是，市場透過研發、策略合作和產品多樣化來促進競爭。該領域的公司不斷投資研發，以研發針對各種類型痤瘡（從輕度到重度）的新藥物和療法。與皮膚科醫生和護膚專家的合作有助於推廣其產品，提升信譽並擴大市場影響力。此外，包括數位行銷和社交媒體在內的行銷策略在推廣產品和教育消費者有效痤瘡管理方面發揮關鍵作用。競爭格局強調了品質、安全和創新在滿足尋求痤瘡治療的個人多樣化需求方面的重要性，最終使消費者受益於更廣泛的選擇和更完善的解決方案。

市場研究報告也對市場競爭格局進行了全面分析。報告涵蓋了市場結構、關鍵參與者定位、最佳制勝策略、競爭儀錶板和公司評估象限等競爭分析。此外，報告還提供了所有主要公司的詳細資料。痤瘡藥物行業的一些主要市場參與者包括：

  • 艾爾建公司
  • 博士倫保健公司
  • 拜耳股份公司
  • Cipher製藥公司
  • 高德美控股公司
  • 強生公司
  • 輝瑞公司
  • 利潔時集團
  • Skinvisible製藥公司
  • 太陽製藥工業有限公司
  • 梯瓦製藥工業股份有限公司

本報告回答的關鍵問題

  • 全球痤瘡藥物市場有多大
  • 2025-2033年全球痤瘡藥物市場的預期成長率是多少
  • 推動全球痤瘡藥物市場的關鍵因素有哪些
  • COVID-19 對全球痤瘡藥物市場有何影響
  • 根據藥物類別，全球痤瘡藥物市場如何分類
  • 根據給藥途徑，全球痤瘡藥物市場如何分佈
  • 全球痤瘡藥物市場的主要區域有哪些
  • 全球痤瘡藥物市場的主要參與者/公司是誰

本報告回答的關鍵問題

  • 全球痤瘡藥物市場有多大？ 2025-2033年全球痤瘡藥物市場的預期成長率是多少？
  • 推動全球痤瘡藥物市場發展的關鍵因素有哪些？
  • COVID-19 對全球痤瘡藥物市場有何影響？
  • 根據藥物類別，全球痤瘡藥物市場是如何分佈的？
  • 根據給藥途徑，全球痤瘡藥物市場如何分佈？
  • 全球痤瘡藥物市場的主要區域有哪些？
  • 全球痤瘡藥物市場的主要參與者/公司有哪些？

目錄

第1章：前言

第2章：範圍與方法

  • 研究目標
  • 利害關係人
  • 資料來源
    • 主要來源
    • 次要來源
  • 市場評估
    • 自下而上的方法
    • 自上而下的方法
  • 預測方法

第3章：執行摘要

第4章：簡介

第5章：全球痤瘡藥物市場

  • 市場概覽
  • 市場表現
  • COVID-19的影響
  • 市場預測

第6章：市場細分：按痤瘡類型

  • 粉刺性
  • 發炎
  • 囊性
  • 手術後/傷口

第7章：市場區隔：依藥品類別

  • 類視黃酸
  • 抗生素
  • 荷爾蒙藥物
  • 聯合用藥
  • 其他

第8章：市場區隔：依藥物類型

  • 非處方藥
  • 處方藥

第9章：市場細分：依行政途徑

  • 外用
  • 口服
  • 注射劑

第10章：市場細分：按地區

  • 北美洲
    • 美國
    • 加拿大
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 韓國
    • 澳洲
    • 印尼
    • 其他
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙
    • 俄羅斯
    • 其他
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他
  • 中東和非洲

第 11 章：SWOT 分析

第 12 章：價值鏈分析

第 13 章：波特五力分析

第 14 章：價格分析

第 15 章：競爭格局

  • 市場結構
  • 關鍵參與者
  • 關鍵參與者簡介
    • Allergan Plc
    • Bausch Health Companies Inc.
    • Bayer Aktiengesellschaft
    • Cipher Pharmaceuticals Inc.
    • Galderma Holding SA
    • Johnson & Johnson
    • Pfizer Inc.
    • Reckitt Benckiser Group Plc
    • Skinvisible Pharmaceuticals Inc.
    • Sun Pharmaceutical Industries Limited
    • Teva Pharmaceutical Industries Ltd.
Product Code: SR112025A2359

The global acne drugs market size reached USD 7.2 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 11.2 Billion by 2033, exhibiting a growth rate (CAGR) of 4.9% during 2025-2033. The market is primarily driven by the rising prevalence of acne among adults and adolescents, the increasing awareness and emphasis on skincare, the ongoing advancements in pharmaceutical R&D for innovative treatments, and the emerging social media influence.

Global Acne Drugs Market Trends:

Increasing Prevalence of Acne

The increasing prevalence of acne among adults and adolescents across the globe is primarily driving the acne drug market statistics. Moreover, the rising hormonal changes during puberty, high stress levels of individuals, and several lifestyle factors, including poor diet and inadequate skincare routines are anticipated to propel the market growth forward. Besides this, the extensive research and development efforts by the major pharmaceutical companies for creative innovative, accessible, and reliable acne medications are also positively influencing the market expansion. For instance, the data published by ClickPharmacy reported that 34% of United Kingdom adults have suffered from acne at some point in their lives. The same source mentioned that 6.1% of men are currently suffering from acne when compared to 2.5% of women. Also, the article published by Sahel Medical Journal mentioned that the prevalence of acne vulgaris in South Nigeria was 37.3% with a higher prevalence in females (37.6%) than in males (36.7%). On account of this, numerous key players are focusing on the introduction of adequate acne treatment solutions to reach out to a large patient base suffering from acne. For example, in June 2023, Sun Pharmaceutical Industries Ltd., received approval from Health Canada, the country's health regulator, for its WINLEVI cream, used in treating acne and acne scars.

Growing Awareness and Emphasis on Skincare

The growing emphasis and awareness regarding skincare and personal appearance is augmenting the acne drugs market growth. Moreover, the inflating expenditures by individuals, especially in developing economies, on skincare products and treatments that aid in achieving clear and blemish-free skin are also catalyzing the global market. Besides this, the increasing influence of social media and celebrity endorsements and the escalating demand for therapies that enhance the appearance of the skin are also positively influencing the market growth. For example, Galderma launched a new digital campaign. "Me Being Me" for topical acne treatment with Aklief (trifarotene) Cream. The company educated patients about Aklief, which is the first new retinoid molecule to gain approval for acne vulgaris in more than 20 years. In addition to this, Stryke Club introduced retinoid acne treatment with its Knockout Adapalene Gel that prevents pimples, blackheads, whiteheads, and clogged pores. Moreover, in September 2023, Marksans Pharma completed the acquisition of Teva Pharmaceuticals in India to continue providing an uninterrupted supply of Teva's important medicines to customers and patients.

Advancements in Pharmaceutical Research and Development

The continuous advancements in pharmaceutical research and development for creating innovative and more efficient formulations for acne treatment are positively influencing the market growth. In addition to this, the inflating investments by regulatory authorities in the study and introduction of the latest and improved acne drugs are also propelling the market expansion. Moreover, the growing popularity of improved drug delivery systems, the discovery of novel active ingredients, and the widespread adoption of combination therapies that target various aspects of acne are further catalyzing the acne drug market revenue. For instance, Galderma announced the U.S. launch of its "Twyneo" Cream, 0.1%/3% at the American Academy of Dermatology (AAD) Annual Meeting in Boston, Massachusetts. TWYNEO Cream is the first and only 0.1% tretinoin and 3% benzoyl peroxide (BPO) 2-in-1 combination proven to rapidly treat moderate to severe facial acne. Moreover, in May 2023, Bausch Health Companies Inc. announced that the U.S. Food and Drug Administration (FDA) accepted the New Drug Application (NDA) for investigational IDP-126 (clindamycin 1.2%/adapalene 0.15%/benzoyl peroxide 3.1%) Gel with a Prescription Drug User Fee Act (PDUFA).

Global Acne Drugs Market Segmentation

Breakup by Acne Type:

  • Comedonal
  • Inflammatory
  • Cystic
  • Postsurgical/Wound

In the comedonal segment, the high prevalence of non-inflammatory acne cases, increasing accessibility to over-the-counter remedies, and the desire for clear, blemish-free skin are primarily driving the market growth. Besides this, the escalating demand for potent anti-inflammatory agents and the ongoing research activities for the development of effective acne treatment solutions are catalyzing the market in the inflammatory segment. Moreover, the rising need for prescription-based medications, the growing popularity of advanced therapies, the elevating requirement for post-procedure skincare, and the emerging trend of cosmetic surgeries, are propelling the expansion of the acne drugs market in the cystic and postsurgical/wound segments.

Breakup by Drug Class:

  • Retinoids
  • Antibiotics
  • Hormonal Agents
  • Combination Drugs
  • Others

Retinoids dominate the market

The rising awareness towards the utilization of retinoids in acne treatment is majorly fueling the market growth in this segment. Besides this, the extensive product need among healthcare professionals and individuals for effective acne treatment, owing to their ability to regulate skin cell turnover, prevent the formation of comedones (blackheads and whiteheads), and reduce inflammation, is augmenting the market growth further.

Breakup by Drug Type:

  • OTC Drugs
  • Prescription Drugs

The easy accessibility of over-the-counter (OTC) drugs and the increasing individual interest in self-care solutions are bolstering the growth of the acne drug market in this segment. Besides this, the rising need for quick remedies, which are readily available in supermarkets, pharmacies, and online outlets, among consumers for common skin concerns is positively influencing the demand for acne drugs globally. For instance, Sun Pharma teamed up with dermatologist Dr. Sandra Lee on the TLC network to spotlight the role of hormones in the underlying cause of skin acne through a campaign called 'AH-ha! It's Acne Hormones'. The campaign featured a diverse group of people of age, gender, and ethnicity and guided the population of the U.S. to follow an effective skin care regimen that may involve OTC products.

Breakup by Route of Administration:

  • Topical
  • Oral
  • Injectable

Topical holds the largest share in the market

The convenience of topical treatments plays a significant role in the acne drug market outlook, as these products are easy to apply directly to affected areas, making them a preferred choice for several individuals seeking localized acne management. Besides this, the ongoing research and development efforts in the pharmaceutical sector for the introduction of innovative formulations with fewer side effects and better outcomes are also catalyzing the market growth in this segment. For instance, the U.S. FDA approved Opzelura (ruxolitinib), a cream for treating mild to moderate atopic dermatitis in patients aged 12 years and older who are not able to use other treatments or fail to get enough symptom relief from other therapies.

Breakup by Region:

  • North America
    • United States
    • Canada
  • Asia-Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Others
  • Europe
    • Germany
    • France
    • United Kingdom
    • Italy
    • Spain
    • Russia
    • Others
  • Latin America
    • Brazil
    • Mexico
    • Others
  • Middle East and Africa

North America exhibits a clear dominance, accounting for the largest acne drugs market share

The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America accounted for the largest market share.

North America represented the largest segment for the acne drugs market, owing to its advanced healthcare infrastructure and the inflating expenditure capacities of individuals. Besides this, the high prevalence of acne among adolescents and adults, the development of state-of-the-art medical technology, and the easy accessibility to medical professionals and dermatologists are also catalyzing the growth of the market in this region. In addition to this, the rising individual inclination towards maintaining their appearance and beauty is positively influencing the market growth. For instance, in Canada, Bausch Health's subsidiary Ortho Dermatologics announced positive topline data from its second Phase III trial for IDP-126, a three-compound combination gel tested in 193 patients with acne vulgaris. This clinical trial showed reductions in both inflammatory and non-inflammatory lesions at week 12 in both problems. IDP-126 combines adapalene, retinol, and anti-microbial benzoyl peroxide.

Competitive Landscape:

The competitive landscape of the global acne drugs market is characterized by a diverse array of pharmaceutical and healthcare companies striving to offer innovative and effective solutions for acne treatment. While specific players are not mentioned here due to the user's request, it's important to note that the market fosters competition through research and development, strategic collaborations, and product diversification. Companies within this space are continually investing in R&D to formulate new medications and therapies that target various types of acne, ranging from mild to severe cases. Partnerships with dermatologists and skincare experts help in endorsing their products, adding credibility and market reach. Furthermore, marketing strategies, including digital marketing and social media, play a pivotal role in promoting their products and educating consumers about effective acne management. The competitive landscape emphasizes the importance of quality, safety, and innovation in addressing the diverse needs of individuals seeking acne treatments, ultimately benefiting consumers with a wider range of options and improved solutions.

The market research report has also provided a comprehensive analysis of the competitive landscape in the market. Competitive analysis such as market structure, key player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided. Some of the major market players in the Acne Drugs industry include:

  • Allergan Plc
  • Bausch Health Companies Inc.
  • Bayer Aktiengesellschaft
  • Cipher Pharmaceuticals Inc.
  • Galderma Holding SA
  • Johnson & Johnson
  • Pfizer Inc.
  • Reckitt Benckiser Group Plc
  • Skinvisible Pharmaceuticals Inc.
  • Sun Pharmaceutical Industries Limited
  • Teva Pharmaceutical Industries Ltd.

Key Questions Answered in This Report

  • 1.How big is the global acne drugs market?
  • 2.What is the expected growth rate of the global acne drugs market during 2025-2033?
  • 3.What are the key factors driving the global acne drugs market?
  • 4.What has been the impact of COVID-19 on the global acne drugs market?
  • 5.What is the breakup of the global acne drugs market based on the drug class?
  • 6.What is the breakup of the global acne drugs market based on the route of administration?
  • 7.What are the key regions in the global acne drugs market?
  • 8.Who are the key players/companies in the global acne drugs market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Acne Drugs Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Acne Type

  • 6.1 Comedonal
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Inflammatory
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Cystic
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast
  • 6.4 Postsurgical/Wound
    • 6.4.1 Market Trends
    • 6.4.2 Market Forecast

7 Market Breakup by Drug Class

  • 7.1 Retinoids
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Antibiotics
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Hormonal Agents
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 Combination Drugs
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast
  • 7.5 Others
    • 7.5.1 Market Trends
    • 7.5.2 Market Forecast

8 Market Breakup by Drug Type

  • 8.1 OTC Drugs
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Prescription Drugs
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast

9 Market Breakup by Route of Administration

  • 9.1 Topical
    • 9.1.1 Market Trends
    • 9.1.2 Market Forecast
  • 9.2 Oral
    • 9.2.1 Market Trends
    • 9.2.2 Market Forecast
  • 9.3 Injectable
    • 9.3.1 Market Trends
    • 9.3.2 Market Forecast

10 Market Breakup by Region

  • 10.1 North America
    • 10.1.1 United States
      • 10.1.1.1 Market Trends
      • 10.1.1.2 Market Forecast
    • 10.1.2 Canada
      • 10.1.2.1 Market Trends
      • 10.1.2.2 Market Forecast
  • 10.2 Asia Pacific
    • 10.2.1 China
      • 10.2.1.1 Market Trends
      • 10.2.1.2 Market Forecast
    • 10.2.2 Japan
      • 10.2.2.1 Market Trends
      • 10.2.2.2 Market Forecast
    • 10.2.3 India
      • 10.2.3.1 Market Trends
      • 10.2.3.2 Market Forecast
    • 10.2.4 South Korea
      • 10.2.4.1 Market Trends
      • 10.2.4.2 Market Forecast
    • 10.2.5 Australia
      • 10.2.5.1 Market Trends
      • 10.2.5.2 Market Forecast
    • 10.2.6 Indonesia
      • 10.2.6.1 Market Trends
      • 10.2.6.2 Market Forecast
    • 10.2.7 Others
      • 10.2.7.1 Market Trends
      • 10.2.7.2 Market Forecast
  • 10.3 Europe
    • 10.3.1 Germany
      • 10.3.1.1 Market Trends
      • 10.3.1.2 Market Forecast
    • 10.3.2 France
      • 10.3.2.1 Market Trends
      • 10.3.2.2 Market Forecast
    • 10.3.3 United Kingdom
      • 10.3.3.1 Market Trends
      • 10.3.3.2 Market Forecast
    • 10.3.4 Italy
      • 10.3.4.1 Market Trends
      • 10.3.4.2 Market Forecast
    • 10.3.5 Spain
      • 10.3.5.1 Market Trends
      • 10.3.5.2 Market Forecast
    • 10.3.6 Russia
      • 10.3.6.1 Market Trends
      • 10.3.6.2 Market Forecast
    • 10.3.7 Others
      • 10.3.7.1 Market Trends
      • 10.3.7.2 Market Forecast
  • 10.4 Latin America
    • 10.4.1 Brazil
      • 10.4.1.1 Market Trends
      • 10.4.1.2 Market Forecast
    • 10.4.2 Mexico
      • 10.4.2.1 Market Trends
      • 10.4.2.2 Market Forecast
    • 10.4.3 Others
      • 10.4.3.1 Market Trends
      • 10.4.3.2 Market Forecast
  • 10.5 Middle East and Africa
    • 10.5.1 Market Trends
    • 10.5.2 Market Breakup by Country
    • 10.5.3 Market Forecast

11 SWOT Analysis

  • 11.1 Overview
  • 11.2 Strengths
  • 11.3 Weaknesses
  • 11.4 Opportunities
  • 11.5 Threats

12 Value Chain Analysis

13 Porters Five Forces Analysis

  • 13.1 Overview
  • 13.2 Bargaining Power of Buyers
  • 13.3 Bargaining Power of Suppliers
  • 13.4 Degree of Competition
  • 13.5 Threat of New Entrants
  • 13.6 Threat of Substitutes

14 Price Analysis

15 Competitive Landscape

  • 15.1 Market Structure
  • 15.2 Key Players
  • 15.3 Profiles of Key Players
    • 15.3.1 Allergan Plc
      • 15.3.1.1 Company Overview
      • 15.3.1.2 Product Portfolio
      • 15.3.1.3 Financials
      • 15.3.1.4 SWOT Analysis
    • 15.3.2 Bausch Health Companies Inc.
      • 15.3.2.1 Company Overview
      • 15.3.2.2 Product Portfolio
    • 15.3.3 Bayer Aktiengesellschaft
      • 15.3.3.1 Company Overview
      • 15.3.3.2 Product Portfolio
      • 15.3.3.3 Financials
      • 15.3.3.4 SWOT Analysis
    • 15.3.4 Cipher Pharmaceuticals Inc.
      • 15.3.4.1 Company Overview
      • 15.3.4.2 Product Portfolio
      • 15.3.4.3 Financials
    • 15.3.5 Galderma Holding SA
      • 15.3.5.1 Company Overview
      • 15.3.5.2 Product Portfolio
    • 15.3.6 Johnson & Johnson
      • 15.3.6.1 Company Overview
      • 15.3.6.2 Product Portfolio
      • 15.3.6.3 Financials
      • 15.3.6.4 SWOT Analysis
    • 15.3.7 Pfizer Inc.
      • 15.3.7.1 Company Overview
      • 15.3.7.2 Product Portfolio
      • 15.3.7.3 Financials
      • 15.3.7.4 SWOT Analysis
    • 15.3.8 Reckitt Benckiser Group Plc
      • 15.3.8.1 Company Overview
      • 15.3.8.2 Product Portfolio
      • 15.3.8.3 Financials
      • 15.3.8.4 SWOT Analysis
    • 15.3.9 Skinvisible Pharmaceuticals Inc.
      • 15.3.9.1 Company Overview
      • 15.3.9.2 Product Portfolio
    • 15.3.10 Sun Pharmaceutical Industries Limited
      • 15.3.10.1 Company Overview
      • 15.3.10.2 Product Portfolio
      • 15.3.10.3 Financials
      • 15.3.10.4 SWOT Analysis
    • 15.3.11 Teva Pharmaceutical Industries Ltd.
      • 15.3.11.1 Company Overview
      • 15.3.11.2 Product Portfolio
      • 15.3.11.3 Financials
      • 15.3.11.4 SWOT Analysis

List of Figures

  • Figure 1: Global: Acne Drugs Market: Major Drivers and Challenges
  • Figure 2: Global: Acne Drugs Market: Sales Value (in Billion USD), 2019-2024
  • Figure 3: Global: Acne Drugs Market: Breakup by Acne Type (in %), 2024
  • Figure 4: Global: Acne Drugs Market: Breakup by Drug Class (in %), 2024
  • Figure 5: Global: Acne Drugs Market: Breakup by Drug Type (in %), 2024
  • Figure 6: Global: Acne Drugs Market: Breakup by Route of Administration (in %), 2024
  • Figure 7: Global: Acne Drugs Market: Breakup by Region (in %), 2024
  • Figure 8: Global: Acne Drugs Market Forecast: Sales Value (in Billion USD), 2025-2033
  • Figure 9: Global: Acne Drugs (Comedonal) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 10: Global: Acne Drugs (Comedonal) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 11: Global: Acne Drugs (Inflammatory) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 12: Global: Acne Drugs (Inflammatory) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 13: Global: Acne Drugs (Cystic) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 14: Global: Acne Drugs (Cystic) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 15: Global: Acne Drugs (Postsurgical/Wound) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 16: Global: Acne Drugs (Postsurgical/Wound) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 17: Global: Acne Drugs (Retinoids) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 18: Global: Acne Drugs (Retinoids) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 19: Global: Acne Drugs (Antibiotics) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 20: Global: Acne Drugs (Antibiotics) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 21: Global: Acne Drugs (Hormonal Agents) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 22: Global: Acne Drugs (Hormonal Agents) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 23: Global: Acne Drugs (Combination Drugs) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 24: Global: Acne Drugs (Combination Drugs) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 25: Global: Acne Drugs (Other Drug Classes) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 26: Global: Acne Drugs (Other Drug Classes) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 27: Global: Acne Drugs (OTC Drugs) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 28: Global: Acne Drugs (OTC Drugs) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 29: Global: Acne Drugs (Prescription Drugs) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 30: Global: Acne Drugs (Prescription Drugs) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 31: Global: Acne Drugs (Topical) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 32: Global: Acne Drugs (Topical) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 33: Global: Acne Drugs (Oral) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 34: Global: Acne Drugs (Oral) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 35: Global: Acne Drugs (Injectable) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 36: Global: Acne Drugs (Injectable) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 37: North America: Acne Drugs Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 38: North America: Acne Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 39: United States: Acne Drugs Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 40: United States: Acne Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 41: Canada: Acne Drugs Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 42: Canada: Acne Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 43: Asia Pacific: Acne Drugs Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 44: Asia Pacific: Acne Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 45: China: Acne Drugs Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 46: China: Acne Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 47: Japan: Acne Drugs Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 48: Japan: Acne Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 49: India: Acne Drugs Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 50: India: Acne Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 51: South Korea: Acne Drugs Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 52: South Korea: Acne Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 53: Australia: Acne Drugs Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 54: Australia: Acne Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 55: Indonesia: Acne Drugs Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 56: Indonesia: Acne Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 57: Others: Acne Drugs Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 58: Others: Acne Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 59: Europe: Acne Drugs Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 60: Europe: Acne Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 61: Germany: Acne Drugs Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 62: Germany: Acne Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 63: France: Acne Drugs Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 64: France: Acne Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 65: United Kingdom: Acne Drugs Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 66: United Kingdom: Acne Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 67: Italy: Acne Drugs Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 68: Italy: Acne Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 69: Spain: Acne Drugs Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 70: Spain: Acne Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 71: Russia: Acne Drugs Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 72: Russia: Acne Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 73: Others: Acne Drugs Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 74: Others: Acne Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 75: Latin America: Acne Drugs Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 76: Latin America: Acne Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 77: Brazil: Acne Drugs Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 78: Brazil: Acne Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 79: Mexico: Acne Drugs Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 80: Mexico: Acne Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 81: Others: Acne Drugs Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 82: Others: Acne Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 83: Middle East and Africa: Acne Drugs Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 84: Middle East and Africa: Acne Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 85: Global: Acne Drugs Industry: SWOT Analysis
  • Figure 86: Global: Acne Drugs Industry: Value Chain Analysis
  • Figure 87: Global: Acne Drugs Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Acne Drugs Market: Key Industry Highlights, 2024 and 2033
  • Table 2: Global: Acne Drugs Market Forecast: Breakup by Acne Type (in Million USD), 2025-2033
  • Table 3: Global: Acne Drugs Market Forecast: Breakup by Drug Class (in Million USD), 2025-2033
  • Table 4: Global: Acne Drugs Market Forecast: Breakup by Drug Type (in Million USD), 2025-2033
  • Table 5: Global: Acne Drugs Market Forecast: Breakup by Route of Administration (in Million USD), 2025-2033
  • Table 6: Global: Acne Drugs Market Forecast: Breakup by Region (in Million USD), 2025-2033
  • Table 7: Global: Acne Drugs Market Structure
  • Table 8: Global: Acne Drugs Market: Key Players